Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges
Yusuke Echigoya, Kenji Rowel Q. Lim, Akinori Nakamura, et al.
Journal of Personalized Medicine (2018) Vol. 8, Iss. 4, pp. 41-41
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Base editing: advances and therapeutic opportunities
Elizabeth M. Porto, Alexis C. Komor, Ian M. Slaymaker, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 12, pp. 839-859
Open Access | Times Cited: 351
Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing
Francesco Chemello, Andreas C. Chai, Hui Li, et al.
Science Advances (2021) Vol. 7, Iss. 18
Open Access | Times Cited: 179
Degenerative and regenerative pathways underlying Duchenne muscular dystrophy revealed by single-nucleus RNA sequencing
Francesco Chemello, Zhaoning Wang, Hui Li, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 47, pp. 29691-29701
Open Access | Times Cited: 125
Correction of muscular dystrophies by CRISPR gene editing
Francesco Chemello, Rhonda Bassel‐Duby, Eric N. Olson
Journal of Clinical Investigation (2020) Vol. 130, Iss. 6, pp. 2766-2776
Open Access | Times Cited: 79
CRISPR Modeling and Correction of Cardiovascular Disease
Ning Liu, Eric N. Olson
Circulation Research (2022) Vol. 130, Iss. 12, pp. 1827-1850
Open Access | Times Cited: 63
Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders
Sibylle Jablonka, Luisa Hennlein, Michael Sendtner
Neurological Research and Practice (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 52
CRISPR Therapeutics for Duchenne Muscular Dystrophy
Esra Erkut, Toshifumi Yokota
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1832-1832
Open Access | Times Cited: 42
Recent Trends in Antisense Therapies for Duchenne Muscular Dystrophy
Harry Wilton-Clark, Toshifumi Yokota
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 778-778
Open Access | Times Cited: 33
Early Cardiac Dysfunction in Duchenne Muscular Dystrophy: A Case Report and Literature Update
Maria Lupu, Irina Pintilie, Raluca Ioana Teleanu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1685-1685
Open Access | Times Cited: 1
Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies
Andreas Brodehl, Hans Ebbinghaus, Marcus-André Deutsch, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4381-4381
Open Access | Times Cited: 66
The lncRNA H19 alleviates muscular dystrophy by stabilizing dystrophin
Yaohua Zhang, Yajuan Li, Qingsong Hu, et al.
Nature Cell Biology (2020) Vol. 22, Iss. 11, pp. 1332-1345
Open Access | Times Cited: 64
Thyroid-stimulating hormone receptor signaling restores skeletal muscle stem cell regeneration in rats with muscular dystrophy
Valentina Taglietti, Kaouthar Kefi, Lea Rivera, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 685
Closed Access | Times Cited: 21
Identification of Splice Variants and Isoforms in Transcriptomics and Proteomics
Taojunfeng Su, Michael A. R. Hollas, Ryan T. Fellers, et al.
Annual Review of Biomedical Data Science (2023) Vol. 6, Iss. 1, pp. 357-376
Open Access | Times Cited: 18
Advances in Dystrophinopathy Diagnosis and Therapy
Fawzy A. Saad, Gabriele Siciliano, C. Angelini
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1319-1319
Open Access | Times Cited: 17
Recent advances in genome editing of stem cells for drug discovery and therapeutic application
Jaesuk Lee, Delger Bayarsaikhan, Govigerel Bayarsaikhan, et al.
Pharmacology & Therapeutics (2020) Vol. 209, pp. 107501-107501
Open Access | Times Cited: 45
Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy
Vratko Himič, Kay E. Davies
European Journal of Human Genetics (2021) Vol. 29, Iss. 9, pp. 1369-1376
Open Access | Times Cited: 35
Modulation of RNA Splicing by Oligonucleotides: Mechanisms of Action and Therapeutic Implications
Olga V. Sergeeva, Evgeniya Shcherbinina, Noam Shomron, et al.
Nucleic Acid Therapeutics (2022) Vol. 32, Iss. 3, pp. 123-138
Closed Access | Times Cited: 25
Antisense and Gene Therapy Options for Duchenne Muscular Dystrophy Arising from Mutations in the N-Terminal Hotspot
Harry Wilton-Clark, Toshifumi Yokota
Genes (2022) Vol. 13, Iss. 2, pp. 257-257
Open Access | Times Cited: 24
Exons 45–55 Skipping Using Mutation-Tailored Cocktails of Antisense Morpholinos in the DMD Gene
Yusuke Echigoya, Kenji Rowel Q. Lim, Dyanna Melo, et al.
Molecular Therapy (2019) Vol. 27, Iss. 11, pp. 2005-2017
Open Access | Times Cited: 37
Genotype–Phenotype Correlations in Duchenne and Becker Muscular Dystrophy Patients from the Canadian Neuromuscular Disease Registry
Kenji Rowel Q. Lim, Quynh Nguyen, Toshifumi Yokota
Journal of Personalized Medicine (2020) Vol. 10, Iss. 4, pp. 241-241
Open Access | Times Cited: 33
A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort
André Mégarbané, Sami Bizzari, Asha Deepthi, et al.
Journal of Neuromuscular Diseases (2021) Vol. 9, Iss. 1, pp. 193-210
Open Access | Times Cited: 31
Retinal cadherins and the retinal cadherinopathies: Current concepts and future directions
Imran H. Yusuf, Andrew M. Garrett, Robert E. MacLaren, et al.
Progress in Retinal and Eye Research (2022) Vol. 90, pp. 101038-101038
Open Access | Times Cited: 21
Advances in CRISPR/Cas9 Genome Editing for the Treatment of Muscular Dystrophies
Sina Fatehi, Ryan M. Marks, M. Rok, et al.
Human Gene Therapy (2023) Vol. 34, Iss. 9-10, pp. 388-403
Closed Access | Times Cited: 12
Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy
Natássia M. Vieira, Janelle M. Spinazzola, Matthew S. Alexander, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 23, pp. 6080-6085
Open Access | Times Cited: 36
Cardiac Involvement in Dystrophin-Deficient Females: Current Understanding and Implications for the Treatment of Dystrophinopathies
Kenji Rowel Q. Lim, Narin Sheri, Quynh Nguyen, et al.
Genes (2020) Vol. 11, Iss. 7, pp. 765-765
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top